Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis
May 24-25, 2004
Bethesda, Maryland, USA
A Scientific Meeting
Sponsored by the American Society for Bone and Mineral Research (ASBMR)
and Co-Sponsored by
The American Academy of Orthopaedic Surgeons (AAOS)
The Endocrine Society (ENDO)
The International Society for Clinical Densitometry (ISCD)
The National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK)
The National Institute on Aging (NIA)
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
The National Institute of Child Health and Human Development (NICHD)
The National Institute of Dental and Craniofacial Research (NIDCR)
The National Osteoporosis Foundation (NOF)
The Osteogenesis Imperfecta Foundation (OIF)
Venue | Meeting Program |
Abstracts | Travel Grants
| Presenter Responsibilities | Registration
Info | Hotel Info | Travel |
Co-Sponsors | Supporters |
Venue
The Advances in Skeletal Anabolic Agents for the Treatment of
Osteoporosis Scientific Meeting will be held May 24-25, 2004, at the Hyatt
Regency Bethesda in Bethesda, Maryland, USA.
Meeting Program
Meeting Organizers
- Andrew F. Stewart, M.D., Chairperson, University of Pittsburgh Medical
Center, Pittsburgh, Pennsylvania, USA
- Robert Nissenson, Ph.D., VA Medical Center, San Francisco, California,
USA
- Clifford J. Rosen, M.D., St. Joseph Hospital, Bangor, Maine, USA
This small, two-day meeting will review the current status of
the field and explore future directions for clinical and basic research in
anabolic agents for metabolic bone diseases. Advances in the understanding
of osteoblastic bone formation, and the explosion in identification of many
new potential signaling molecules and transcriptional targets, have made this
an exciting time for researchers and clinicians alike.
In addition to the invited speaker program, there are two Young
Investigator Oral Sessions, reserved for young investigators. Each of these
sessions has four oral presentation slots which have been assigned to the
top ranking young investigator abstract submitters.
All other abstracts have been assigned to a poster session.
Session Topics
- Exercise, Calcium and Vitamin D as Skeletal Anabolic Agents
- Skeletal Anabolism: Transcription Regulation and Signaling
- LRP5, Wnt and High Bone Mass
- Estrogens and SERMs
- Growth Hormones and Growth Factors
- PTH and PTHrP
- Miscellaneous Anabolic Agents
Basic and clinical questions addressed will include:
-
How do exercise, calcium and vitamin D function as
skeletal anabolic agents?
-
What do we know about transcriptional regulation and
signaling in skeletal anabolism?
-
How do estrogens and SERMs function as anabolic agents?
-
What are the role of growth hormones and growth factors?
-
How do PTH and PTHrP function clinically and on a
basic level?
-
What are the risks and side effects?
-
How might anabolic agents be used to promote bone
healing?
-
What does the future hold for miscellaneous anabolic
agents under investigation?
Abstracts
The abstracts submission deadline for this meeting was Wednesday,
February 18, 2004, at 5:00 p.m. Central Standard Time.
Program Assignment Notification
Abstracts have been assigned to either a Young Investigator Oral Session or
to a Poster Session. There are two Young Investigator Oral Sessions, reserved
for young investigators. Each session has four oral presentation slots which
have been assigned to the top ranking young investigator abstract submitters.
All other abstracts were assigned to a poster session, as long as space permits.
Please see below for poster and slide information.
Poster
Instructions
Poster Schedule
Slide Presentation
Instructions
Travel Grants for Young
Investigators
A minimum of 15 Young Investigator Travel Grants will be awarded
for this meeting. The Organizing Committee will select award recipients based
on the abstract’s scientific merit. All abstracts will be scored using
a “blind review” system. Although nominations will not be accepted
for Young Investigator Travel Grants, individuals should indicate eligibility
on the abstract submission form by selecting the submission category Young
Investigator Abstract Submission.
These Young Investigator Travel Grants recognize young investigators
for their excellence in research related to skeletal anabolic agents for the
treatment of osteoporosis. In addition to the scientific merit of
the abstract, the following eligibility requirements apply:
- The individual must be the first and presenting author.
- The individual must be within five years of completion of a Ph.D. or
residency training (for M.D., D.D.S., or their equivalent). The five years
of eligibility are defined to extend from the end of the calendar year
of the graduation date or residency completion to the submission deadline
date (February 18, 2004).
- Also eligible are students and trainees who have not yet graduated,
earned their degrees or completed their residencies.
The award includes a $1,000 honorarium, which will be provided
to the recipient on-site at the ASBMR Advances in Skeletal Anabolic Agents
for the Treatment of Osteoporosis Scientific Meeting. All Young Investigator
Travel Grant recipients must present their abstracts at the meeting.
ASBMR's Expectations of Presenters
Through ASBMR meetings, the Society wishes to promote excellence
in bone and mineral research. Toward that end, ASBMR expects that all presenters
participating in the ASBMR Advances in Skeletal Anabolic Agents for the Treatment
of Osteoporosis Scientific Meeting will provide informative and fully accurate
scientific and other information. Furthermore, the ASBMR expects that all
presentations at this meeting will reflect the highest level of scientific
rigor and integrity.
The content of speaker presentations, slides, and reference
materials must remain the ultimate responsibility of the faculty. The planning,
content and execution of speaker presentations, slides, abstracts and reference
materials should be free from corporate influence or control. Industry-based
and supported presenters should provide full disclosure of their relationship
with the respective company(ies).
Registration Information
Sold Out - Registration for this
meeting is closed.
Conference Meals
Your registration for the conference includes a continental breakfast
and boxed lunch on both Monday and Tuesday, May 24th and 25th, 2004.
Cancellation Policy
Refunds will be made if cancellation is received in writing at
the ASBMR Business Office by the pre-registration deadline of April 30,
2004. All refunds will be processed after the conference and will be less
a $50 administrative fee.
Hotel Information
Headquarter Hotel
Hyatt Regency Bethesda
7400 Wisconsin Avenue
Bethesda, Maryland 20814
USA
Hyatt Regency Reservations:
Tel: 1 (800) 233-1234 (within the U.S. and Canada) or (301) 657-1234
Fax: (301) 657-6453
Travel
ASBMR's travel coordinator, Apollo Travel, has negotiated special air travel
discounts with American Airlines for travel to Bethesda, MD, between May 21
and May 27, 2004. Space may be limited. Fees, restrictions and cancellation
penalties will apply.
Please contact Apollo Travel Agency at (800) 356-2330 (Monday thru Friday,
4:00 am to Midnight CST) within the U.S. and Canada, or (312) 236-3939 (24
hours) within Illinois or internationally. Apollo Travel will proactively
research airfares on ALL airline carriers to ensure that they offer the lowest
available fare. They are dedicated to offering the best customer service for
all attendees. Apollo will also be providing car rental discounts for the
lowest available rates.
American Airlines is offering a 10% discount below the lowest published airfare
and a 15% discount off American's full-unrestricted fares and first class
fares if reservations are made 30 days or more in advance. Within 30 days
these discounts will drop to 5% and 10% respectively.
Airport Transfers
Estimated taxi fees to Hyatt Regency Bethesda from local airports:
-
Reagan National Airport* $35-45
-
Dulles International Airport* $45-50
-
Baltimore/Washington International Airport $60-70
*The Hyatt is located less than 30 minutes from the Reagan National and
Dulles International airports.
Road Directions
The Hyatt Regency Bethesda is located at 7400 Wisconsin Avenue (at Old Georgetown
Road) in Bethesda, Maryland, USA.
From Washington/National Airport (18 miles):
Take George Washington Pkwy west to I-495 North, to Wisconsin Avenue South.
Hotel is on right, 2 miles.
From Dulles International (18 miles):
Take Dulles Access Road east to I-495 North, to Wisconsin Avenue South. Hotel
is on right, 2 miles.
From BWI Airport (32 miles):
Take I-95 South to I-495 West towards Silver Spring/Chevy Chase. Take to Wisconsin
Avenue South. Hotel is on right, 2 miles.
Parking
Garage parking is available on the south side of the hotel, located on Wisconsin
Avenue. The garage rate is $12 per day. Valet parking is also available, for
$14 per day.
Metro
The metropolitan Washington area is serviced by the METRO subway system.
The Hyatt Regency Bethesda is accessible by the METRO subway system from Ronald
Reagan National Airport.
From the Reagan National Airport take the Yellow Line in the direction of Mt.
Vernon Square/UDC to the Gallery Place stop. From there, transfer to the Red
Line in the direction of Shady Grove/Grosvenor. The METRO station for the Hyatt
Regency Bethesda is the Bethesda station on the Red Line.
Co-Sponsors
American Academy of Orthopaedic Surgeons (AAOS)
The Endocrine Society (ENDO)
International Society for Clinical Densitometry (ISCD)
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The National Institute on Aging (NIA)
The National Institute of Arthritis and
Musculoskeletal and Skin Diseases (NIAMS)
The National Institute of Child Health and Human Development (NICHD)
The National Institute of Dental and Craniofacial Research (NIDCR)
National Osteoporosis Foundation (NOF)
Osteogenesis Imperfecta Foundation, Inc. (OIF)
Supporters
The following Institutes from the U.S. National Institutes
of Health provided funding for this meeting through and unrestricted educational
grant (R13DK/AR/HD/DE/AG67034):
The National Institute of Diabetes and Digestive and Kidney Diseases
(NIDDK)
The National Institute on Aging (NIA)
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
The National Institute of Child Health and Human Development (NICHD)
The National Institute of Dental and Craniofacial Research (NIDCR)
The following companies provided funding through unrestricted
educational grants:
Platinum Level
NPS Pharmaceuticals
Gold Level
Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and Aventis
Pharmaceuticals)
Roche and GlaxoSmithKline
Silver Level
Amgen, Inc.
Eli Lilly and Company
Merck & Co., Inc.
Friend Level
Pfizer, Inc.
Wyeth Pharmaceuticals
|
Print page
Email Page